Specialty Pharma Journal
Login
Login
Username
Password
Remember Me
Forgot your password?
Forgot your username?
Create an account
SPJ Journal
News
Business News
Cystic Fibrosis
Diabetes
Endocrinology
Rare Diseases
Growth Hormone
Hematopoietics
Hemophilia
Hepatitis C
Hereditary Angioedema
HIV
Hormonal Therapies
Immune Deficiencies
Infectious Disease
Infertility
Lysosomal Storage Disorders
Macular Degeneration
Multiple Sclerosis
Nephrology
Oncology
Osteoarthritis
Osteoporosis
Postpartum Hemorrhage
Psoriasis
Pulmonary Arterial Hypertension
Pulmonary Disease
Renal Disease
Respiratory Syncytial
Rheumatoid Arthritis
Transplantation
Vaccines and Immunizations
Von Willebrand Disease
About Us
Mission & Vision
Advisory Board
Contact Us
Career Opportunities
SPJ Author Guidelines
Surveys
Blog
Education
Certification
Skip to content
Tue
05
21
2013
Last update
09:29:10 PM EST
Search
Back
Surveys
Fast Acting Fentanyl Needs Assessment Survey Control
Please rate your level of agreement
Due to the requirement of a rapid onset agent on top of chronic pain treatment, an effective agent is needed for the treatment of breakthrough pain associated with cancer (BTPaC).
*
Strongly agree
Agree
Disagree
Strongly Disagree
The pharmacokinetics of fast-acting fentanyl (FAF) products lend to ideal management of BTPaC.
*
Strongly agree
Agree
Disagree
Strongly Disagree
SPJ Surveys
Development of A Specialty Pharmacy Association
Is there a need for new hepatitis C-based educational programs?
What does the future hold for nucleotide polymerase inhibitors for the treatment of Hep C?
Do you agree with the FDA's decision to halt Idenix's Hep C Trial for IDX19368 without having tested the drug on a single patient?
Future of Idenix's Hep C Drug Poll
Weighing the Pros and Cons in Pediatric Hepatitis C Treatment
Updated Breast Cancer Guidelines Survey
Updated ACR RA Guidelines Poll
Medical Health Care Provider Hereditary Angioedema Educational Needs Assessment
Pharmacist IVIG/SCIG Educational Needs Assessment
IG Therapy Needs Assessment for Medical Directors
IG Therapy Needs Assessment for Case Managers
Managed Care Education Needs Assessment
Emerging Pharmacotherapy for Multiple Sclerosis Survey
Risk Evaluation Mitigation Strategies (REMS) Survey
Need Assessment Survey for CE on Insulin Products
Fast Acting Fentanyl Needs Assessment Survey Control
Fast Acting Fentanyl Needs Assessment Survey
